Workshop
“Blockchain in Clinical Trials- How and Why Blockchain and Distributed Ledger Technologies (DLTs) are new disruptive approaches in the Clinical Trials Industry? A pragmatic seminar with views from Blockchain , Pharma and CRO industries professionals”
We are in the midst of a significant shift in pharmaceutical drug development, with the inception of new paradigms and technologies. Blockchain has arrived to fundamentally create a new paradigm patient-centric drug development and healthcare best practice.
For the last 2 years, multiple initiatives are moving the Blockchain for Clinical Trials Conversation from Why to How & When with Industry, Regulatory and the Patient .
This seminar will embrace several views from pharmaceutical professionals, technologists, clinical trial service providers and other stakeholders who are evaluating the viable use cases for Blockchain /distributed ledger technologies
(DLTs).